OIC
Showing 1 - 25 of 92
Behaviors, Health Trial in Hong Kong (HIVST-Chatbot (HIV self-testing services with counseling provided by a Chatbot), HIVST-OIC
Not yet recruiting
- Behaviors, Health
- HIVST-Chatbot (HIV self-testing services with counseling provided by a Chatbot)
- HIVST-OIC (HIV self-testing services with counseling provided by administrators)
-
Hong Kong, Hong KongCentre for Health Behaviours Research, the Chinese University of
Mar 31, 2023
PTSD Trial in Port Chester, Rocky Mount (Written Exposure Therapy (WET))
Recruiting
- PTSD
- Written Exposure Therapy (WET)
-
Port Chester, New York
- +1 more
Oct 27, 2022
NASH Trial in Nottingham (Aramchol)
Completed
- NASH
-
Nottingham, United KingdomQuotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nott
May 23, 2023
Quality of Life in Advanced Cancer Opioid-induced Constipation
Completed
- Opioid Use
- +2 more
- Naloxegol
-
Bologna, BO, ItalyFondazione ANT Italia ONLUS
Feb 10, 2022
Safety Issues Trial in Baton Rouge (Celastrol)
Recruiting
- Safety Issues
- Celastrol
-
Baton Rouge, LouisianaPatient Urgent Care Clinic
Jun 7, 2022
Safety Trial in Baton Rouge (Celastrol)
Recruiting
- Safety
- Celastrol
-
Baton Rouge, LouisianaPatient Plus Urgent Care
Aug 8, 2022
Opioid-Induced Constipation Trial in Dublin
Recruiting
- Opioid-Induced Constipation
-
Dublin, IrelandOur Lady's Hospice & Care Services
Nov 24, 2021
RELISTOR's Effects on Opioid-Induced Constipation
Withdrawn
- OIC
- Relistor Injectable Product
- +6 more
-
Dallas, TexasMethodist Moody Brain and Spine Institute, Methodist Dallas Medi
Apr 27, 2022
Constipation, Signs and Symptoms, Digestive Trial in Worldwide (Naloxegol)
Completed
- Constipation, Signs and Symptoms, Digestive
-
Odense, Denmark
- +15 more
Aug 30, 2022
Opioid Induced Constipation Trial in Pasadena (TD-1211, Placebo)
Completed
- Opioid Induced Constipation
- TD-1211
- Placebo
-
Pasadena, CaliforniaTheravance Biopharma Investigational Site
May 20, 2021
Opioid-induced Constipation (OIC) Trial in Salt Lake City (TD-1211, Placebo)
Completed
- Opioid-induced Constipation (OIC)
- TD-1211
- Placebo
-
Salt Lake City, UtahClinical Research Unit
Jan 19, 2021
OIC Trial in Madison (TD-1211 IV [C14], TD-1211 PO [C14])
Completed
- OIC
- TD-1211 IV [C14]
- TD-1211 PO [C14]
-
Madison, WisconsinCovance
Jan 15, 2021
Constipation Trial in United States (SP-333 1 mg, SP-333 3 mg, SP-333 6 mg)
Completed
- Constipation
- SP-333 1 mg
- +3 more
-
Huntsville, Alabama
- +41 more
May 4, 2021
Study of Multidrug-Resistant Patient Outcomes With and Without
Recruiting
- HIV Infections
- Multi-Antiviral Resistance
- No ibalizumab or Pre-ibalizumab treatment
- On ibalizumab treatment
-
Los Angeles, California
- +38 more
Jan 31, 2023
Study of Opioid-Induced Constipation 2 Project
Completed
- Opioid-induced Constipation
- +2 more
- Treatment algorithm for OIC
-
Truro, Cornwall, United Kingdom
- +15 more
May 22, 2020
Major Adverse Cardiovascular Events for Naldemedine and Other
Recruiting
- Opioid-induced Constipation
- Naldemedine
- +2 more
-
Wilmington, DelawareResearch Site
Feb 28, 2022
Opioid-Induced Constipation Trial in Leuven (Naloxegol, codeine phosphate, Placebo)
Completed
- Opioid-Induced Constipation
- Naloxegol
- +2 more
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Mar 15, 2023
Constipation, Opioid-Induced Trial in Netherlands (Macrogol Only Product in Oral Dose Form, Magnesium hydroxide 724mg)
Not yet recruiting
- Constipation, Opioid-Induced
- Macrogol Only Product in Oral Dose Form
- Magnesium hydroxide 724mg
-
Almere, Flevoland, Netherlands
- +9 more
Jan 30, 2022
Healthy, Opioid-induced Constipation Trial in Pasadena, San Antonio, Salt Lake City (TD-1211, Placebo)
Completed
- Healthy
- Opioid-induced Constipation
- TD-1211
- Placebo
-
Pasadena, California
- +2 more
Jan 15, 2021
Study of Opioid-Induced Constipation 1 Project
Completed
- Opioid-induced Constipation
- +2 more
- Clinical assessment
-
Truro, Cornwall, United Kingdom
- +15 more
Apr 15, 2020
Advance Illness Patients With OIC Trial in Tarrytown (SC Methylnaltrexone, SC Placebo)
Completed
- Advance Illness Patients With OIC
- SC Methylnaltrexone
- SC Placebo
-
Tarrytown, New YorkProgenics Pharmaceuticals, Inc.
Nov 21, 2019
Cardiovascular Disease (CVD) Trial in United States (CHANGE Study)
Completed
- Cardiovascular Disease (CVD)
- CHANGE Study
-
Ahoskie, North Carolina
- +3 more
Oct 4, 2019